Osmotica Pharmaceuticals Plc Profit Margin

Osmotica Pharmaceuticals Plc posts a profit margin of -184.91% as of June 2023. That compares with -161.69% in the prior-year period — down 14.4% year over year. That is below the Healthcare sector average of 13.76%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Osmotica Pharmaceuticals Plc's profit margin was -161.69%. The latest reading is -184.91% — a 14.4% year-over-year decrease (period ending June 2023). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 13.76% is typical. Osmotica Pharmaceuticals Plc's -184.91% is lower that level. That is roughly 1443.8% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Osmotica Pharmaceuticals Plc's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -184.91% as of June 2023; use YoY and peer views to separate noise from signal.

Context for OSMT's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.76%), and (3) consistency with growth and profitability. This page covers the first two; Osmotica Pharmaceuticals Plc's other metric pages and overview cover the third.